Attached files

file filename
EX-99.1 - PRESS RELEASE - IMMUCOR INCex99-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
__________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):              November 8, 2010

IMMUCOR, INC.
(Exact name of registrant as specified in its charter)
 
Georgia
0-14820
22-2408354
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)

3130 Gateway Drive, Norcross, Georgia
30071
(Address of principal executive offices)
 (Zip Code)
 
Registrant's telephone number, including area code: (770) 441-2051

Not Applicable
(Former name or former address,
if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 

Item 8.01.                      Other Events.
 
On November 8, 2010, Immucor, Inc. (the “Company”) announced that the United States Department of Justice, Antitrust Division, has informed the Company that its investigation of the Company has been closed.
 
On November 8, 2010, the Company issued a press release announcing the closing of the investigation.  A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
 
Item 9.01.                      Financial Statements and Exhibits.
 
(d) Exhibits
   
99.1 Press Release, dated November 8, 2010

 
 

 

SIGNATURES
 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
IMMUCOR, INC.
 
       
       
       
Date: November 8, 2010   
By:
/s/ Philip H. Moïse  
   
Philip H. Moïse
 
    Executive Vice President and General Counsel